Physician profile
Ralph W Everson
NPI 1902967391
$1,620.40
in general payments reported to CMS, 2019-2025
18 companies · $156 in 2025
The $156 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,143 · 2020: $125 · 2021: $99.59 · 2023: $13.42 · 2024: $83.90 · 2025: $156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $240.23 | 2024-2025 | Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $222.95 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $174.93 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $153.89 | 2019-2021 | |
| Amgen INC. | $126.35 | 2019-2021 | |
| Glaxosmithkline, LLC. | $102.03 | 2019-2020 | |
| Novo Nordisk INC | $91.48 | 2019 | |
| Pfizer INC. | $83.19 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $75.98 | 2019 | |
| Amarin Pharma, INC. | $68.63 | 2019-2020 | |
| Astellas Pharma US INC | $68.25 | 2019 | |
| Mylan Specialty L.P. | $52.68 | 2019 | |
| Lilly USA, LLC | $52.27 | 2019-2021 | |
| Abbott Laboratories | $31.30 | 2019-2023 | Freestyle Libre 3 |
| Allergan, INC. | $24.66 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $23.76 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.34 | 2020 | |
| Vanda Pharmaceuticals INC. | $13.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ralph Everson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.